Cerebrospinal Fluid Carcinoembryonic Antigen in Patients With Metastatic and Nonmetastatic Neurological Diseases
- 1 March 1986
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 43 (3) , 269-272
- https://doi.org/10.1001/archneur.1986.00520030059015
Abstract
• Cerebrospinal fluid (CSF) carcinoembryonic antigen (CEA) values were determined in 200 patients suffering from various neurological diseases. We found no relationship between CEA levels and age or sex. A positive test was defined as an upper limit of at least 4.0 ng/mL of CEA. We found raised CSF CEA levels in patients with leptomeningeal spread from carcinoma, but not in patients with leptomeningeal metastases from lymphoma. We also found high values of CSF CEA in three of 21 patients with epidural metastases and in two of 28 patients with cerebral metastases from solid tumors. Comparison was made with the CSF levels of total protein, glucose, and lactate dehydrogenase. The sensitivity of the CSF CEA determination in patients for the presence of leptomeningeal involvement of cancer is 31% and the specificity is 90%.This publication has 4 references indexed in Scilit:
- Carcinoembryonic Antigen Assay of Ascites and Detection of MalignancyAnnals of Internal Medicine, 1978
- Present and Probable Uses of CEACA: A Cancer Journal for Clinicians, 1975
- An Analysis of Variance Test for Normality (Complete Samples)Biometrika, 1965
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESThe Journal of Experimental Medicine, 1965